Moderna leaders are committed to expanding the supply until their vaccines' no longer need to come again in low-income countries'.Moderna on 8-10 announcing they target a billion doses of vaccine Preventing Covid-19 for low-income countries in 2022, in addition to the number of vaccines that the company has committed to the Global Covax Vaccine Shared Program. REUTERS, 1 billion doses of pharmaceuticals and biosafety companies Studying the US intends to transfer within the framework of 2 to 3 billion doses of vaccines that the company plans to produce to the year. Vaccine Moderna. Photo: AFP "So far, more than 250 million people have been globally vaccinated with Vaccine Moderna
. However, we recognized that the vaccine approach is still a challenge in many parts of the world "- Moderna's CEO, Mr. Stéphane Bancel said." So we still focus on being Make a comprehensive strategy and always develop to ensure that low-income countries have access to our vaccines, "he added
Before that, on October 7, Moderna announced next Planning to invest to 500 million USD to build a factory in Africa with a capacity of up to 500 million doses of mRNA vaccines every year, including Covid-19 prevention vaccine. Moderna's report is given after Biontech, partner Developing Vaccine Prevent Covid-19 with Pfizer Group, said they will establish a mRNA manufacturing facility in Africa. According to the Financial Times, the German-based vaccine developer has organized negotiations with houses The political leader of Senegal and Rwanda in August and aimed at gaining a partner for the easiest part of the process of closing the jar next year. Only, Moderna is the first company to announce a plan for a completely entirely entirely-owned mRNA factory in the area to produce active ingredients in the Vaccine. May Provide up to 500 million doses of vaccine with Covid-19 for the Covax program from the fourth quarter of this year until next year. "We are committed to doubling production and expanding additional supply until the vaccine of us No longer needed in low-income countries "- Mr. Bancel said." Our responsibility during a pandemic time is to promote themselves to its limits to expand the ability to provide vaccines and heads. In the future to prevent the limitations we face today due to a recurring pandemic "- he stressed. In an interview in Swiss Neue Zuercher Zeitung newspaper last month, he Bancel was optimistic when the Covid-19 Pandemic could end in a year when the production of vaccines was enhanced to ensure source global supply
optical . Dịch vụ:
Thiết kế website,
quảng cáo google,
đăng ký website bộ công thương uy tín
